WO2026074318 - COMPOSITIONS CONTAINING TRIHYDROXYSTEARIN AND OIL FOR INHIBITING TRIHYDROXYSTEARIN CRYSTALLIZATION

National phase entry is expected:
Publication Number WO/2026/074318
Publication Date 09.04.2026
International Application No. PCT/IB2025/000501
International Filing Date 03.10.2025
Title **
[English] COMPOSITIONS CONTAINING TRIHYDROXYSTEARIN AND OIL FOR INHIBITING TRIHYDROXYSTEARIN CRYSTALLIZATION
[French] COMPOSITIONS CONTENANT DE LA TRIHYDROXYSTÉARINE ET DE L'HUILE POUR INHIBER LA CRISTALLISATION DE LA TRIHYDROXYSTÉARINE
Applicants **
L'OREAL
SIMONET, Frédéric
Inventors
FRIOT, Amélie
Priority Data
18/906,267   04.10.2024   US
2413765   10.12.2024   FR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2151
EPO Filing, Examination, Granting8466
Japan Filing, Examination, Granting2122
South Korea Filing, Examination, Granting2037
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,516
Contact Us
Abstract[English] The present disclosure relates to compositions including trihydroxystearin and at least one oil for inhibiting trihydroxystearin crystallization, as well as to methods of making and using such compositions.[French] La présente divulgation concerne des compositions comprenant de la trihydroxystéarine et au moins une huile pour inhiber la cristallisation de la trihydroxystéarine, ainsi que des procédés de fabrication et d'utilisation de telles compositions.